EU Commission unveils 13 targets for overseas raw materials projects
The European Commission announced the selection of 13 projects focused on critical raw materials in countries outside the EU on Wednesday.
The move is part of the implementation of the Critical Raw Materials Act, an EU law that came into force in May 2024, aimed at diversifying the sources of raw material extraction.
The projects aim to reduce dependency on single suppliers, such as China and the US.
They also seek to enhance overall economic security amid geopolitical events, including commercial tensions between the EU and China and the tariffs on steel and aluminium imposed by US President Donald Trump.
The Commission wants to develop 60 such projects before 2030, with the goal of strengthening the bloc's industrial competitiveness, particularly in sectors such as electric mobility, renewable energy, defence, and aerospace.
"Today's list of 13 Strategic Projects across the world will help to reduce Europe's dependencies, contribute to our economic security while creating growth, jobs and export opportunities in the countries concerned," EU Commissioner for industrial strategy Stéphane Séjourné said during the announcement.
These initiatives focus on both extraction and processing of key resources.
Graphite supply is being advanced through projects in Ukraine, Norway, Greenland, Madagascar, and Kazakhstan, while nickel and cobalt production is being addressed in Canada, Brazil, and Zambia.
The Jadar project in Serbia targets lithium and boron, and rare earth elements are being sourced from initiatives in Malawi and South Africa.
Additional efforts include copper extraction in Norway, tungsten mining in the United Kingdom, and nickel processing in New Caledonia.
From Italy to Greece and Portugal, off-label use of GLP-1 drugs like Ozempic and Mounjaro for weight loss is creating a booming private market—and a brewing public health dilemma.
In a matter of just a few years, Europe has witnessed an unprecedented shift in how one class of medications—so-called GLP-1 receptor agonists—is perceived and used.
Originally developed to treat type 2 diabetes, these injectable drugs are now fueling a multibillion-euro weight loss industry, driven by private demand, social media hype, and regulatory gaps.
The new 'weight loss hysteria' started in the United States, where the prices for the drugs remain highest, but people are still willing to pay $1,300 (€1,142) each month without insurance coverage.
The tendency is now exploding in Europe and is not limited to those with medical conditions and obesity, but spreading to those seeking a novel approach to getting a beach-ready body. But what price are we willing to pay for the dream body across Europe?
Italy's private market for GLP-1 drugs exploded in 2024, reaching a staggering €26 billion in global anti-obesity drug spending, a more than tenfold increase compared to 2020.
According to Pharma Data Factory (PDF), private spending on GLP-1 agonists doubled from €52 million in 2023 to over €115 million in 2024.
This surge stems from a rising trend: off-label use of anti-diabetic drugs for weight loss. Since such use is not currently covered by Italy's national health service, most of the spending has come directly from patients' pockets.
There is, however, movement at the policy level. The recent Act No 741, which officially recognises obesity as a chronic disease, may pave the way for future reimbursement under Italy's provisions for insurance Essential Levels of Care (LEA).
For the time being, however, prescriptions are typically limited to specialists and often require proof of a high body mass index or conditions related to diabetes.
The phenomenon is mirrored in Greece, where usage of anti-obesity drugs surged by 82.5% in 2024, with €93 million in total spending. Ozempic's popularity has skyrocketed, and the market has since expanded to include Mounjaro, introduced in November 2024.
Despite consumer enthusiasm, Greek regulations remain among the strictest in Europe.
Prescribing these drugs for obesity is technically forbidden, except in life-threatening cases. Physicians must prove a diagnosis of diabetes to prescribe them, making legitimate weight-loss prescriptions almost impossible through official channels.
But regulatory rigidity has not slowed the underground momentum. With Mounjaro sales now hitting 12,000 units per month, price cuts—such as the 23% drop announced by Pharmaserve-Lilly in February—are expected to further accelerate the drug's spread, whether legal or otherwise.
In Portugal, the weight loss drug phenomenon is newer but no less intense. In the first four months of 2025 alone, Portuguese consumers spent nearly €20 million on GLP-1-based injectables like tirzepatide (Mounjaro) and semaglutide (Wegovy)—both of which are officially approved for obesity treatment.
In just two months of 2024, over 10,000 units of tirzepatide were sold, while Wegovy, introduced in April 2025, has racked up sales of 6,800 units in a single month. With each Wegovy injection costing EUR 244.80, the trend shows no signs of slowing.
Ozempic, while not officially approved for weight loss, continues to be widely used off-label. Its popularity has led to pharmacy stock shortages and forced Infarmed—the national medicines authority—to initiate drug circuit audits in cooperation with the European Medicines Agency.
Reimbursement remains a sticking point. Despite rising interest and usage, Portugal still doesn't subsidise anti-obesity injectables, and the entire cost is borne by individuals—many motivated by influencer culture and celebrity transformations.
According to data from consulting firm IQVIA shared with El Confidencial Digital outlet, the Spanish pharmaceutical market saw turnover for weight-loss medications exceed €484 million in 2024—a 65% increase from €293 million in 2023. Units sold jumped from 3.2 million to 4.8 million, reflecting more than 50% growth in volume.
Yet despite this surge, the Interministerial Commission on Prices of Medicines and Health Products does not publicly track spending specifically on anti-obesity medications.
What is known: Spain's overall retail drug expenditure stands at €412 per capita, 21% below the EU average of €500, according to the 2024 Pharmaceutical Expenditure Report.
In Spain, prices for publicly reimbursed drugs are set by the Ministry of Health, and anti-obesity medications must be prescribed and supervised by specialists.
This regulatory barrier is meant to ensure appropriate use—but it also limits access, particularly as public demand rises faster than policy adapts.
In Germany, demand for weight-loss drugs like Wegovy and Mounjaro is rising fast—yet public coverage remains limited. These GLP-1 medications can cost up to €300 a month, and for most people, the bill comes out of pocket.
By law, Germany's public health insurance system excludes drugs used purely for weight loss, classifying them as lifestyle treatments.
However, exceptions are emerging. In early 2024, authorities made Wegovy eligible for reimbursement—but only in cases where obesity poses a serious cardiovascular risk.
Despite these restrictions, the market is booming. Sales of GLP-1 drugs in Germany are expected to more than double by 2030, reaching over €700 million.
With more than half the adult population overweight, pressure is growing on policymakers to expand access. For now, the debate continues—between cost, public health, and who should benefit from these powerful new medications.
While some countries restrict access, Poland offers surprisingly open availability. Ozempic is reimbursed for diabetic patients (121.25 Polish złoty or €28 with discount), but can also be obtained via telemedicine after a remote consultation—even without diabetes, depending on the doctor's assessment.
The full price of Ozempic is 404 złoty (€94), and demand is high, driven by growing perceptions of the drug as a fast track to weight loss.
France has started a formal review that could lead to reimbursement for Mounjaro in limited obesity cases, but for now, neither Mounjaro nor Wegovy are covered under the public system.
By contrast, the UK's NHS does cover both drugs, with eligibility limited to patients referred to specialist weight management services. Wegovy became available via the NHS in 2023, and Mounjaro followed with rollout in 2024, under structured programs.
Across Europe, public healthcare systems are facing a growing dilemma. Originally designed to manage chronic diseases like diabetes, these systems are now being strained by surging demand for weight-loss drugs such as Ozempic, Wegovy, and Mounjaro.
While obesity is increasingly recognised as a chronic condition, regulatory and reimbursement policies have struggled to keep up.
This mismatch has created a growing shadow market, where people without official diagnoses pay out of pocket.
And buying some of these drugs is actually as easy as buying a detox tea. You just need to lie, click and pay. And then pray that what comes through the post is the real thing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
3 hours ago
- France 24
Italy holds referendum on citizenship, workers' rights
A non-EU adult resident without marriage or blood ties to Italy must currently live in the country for 10 years before they can apply for citizenship -- a process which can then take years. The referendum proposal, triggered by a grassroots campaign led by NGOs, would cut this to five years, putting Italy in line with Germany and France. Campaigners say around 2.5 million people could benefit from the reform, which is being backed by the centre-left Democratic Party. Meloni, whose far-right Brothers of Italy party has prioritised cutting illegal immigration even while increasing the number of legal work visas for migrants, is strongly against it. She said Thursday that the current system "is an excellent law, among the most open, in the sense that we have for years been among the European nations that grant the highest number of citizenships each year". More than 213,500 people acquired Italian citizenship in 2023, double the number in 2020 and one fifth of the European Union total, according to EU statistics. More than 90 percent were from outside the bloc, mostly from Albania and Morocco, as well as Argentina and Brazil -- two countries with large Italian immigrant communities. Ministers agreed in March to restrict the rights to citizenship of those with blood ties to Italy from four to two generations. Meloni and her coalition partners have encouraged voters to boycott the referendum, which will only be valid if 50 percent of eligible voters plus one participate. Even if it passes, the reform will not affect the migration law many consider the most unfair, that children born in Italy to foreign parents cannot request nationality until they reach 18. Prominent rapper Ghali, who was born in Milan to Tunisian parents, has been an outspoken advocate changing the law for children, but nevertheless urged fans to back Sunday's vote as a step in the right direction. "With a 'Yes' we ask that five years of life here are enough, not 10, to be part of this country," he wrote on Instagram. Interests of workers Under Italy's constitution, a referendum can be triggered by a petition signed by at least 500,000 voters. This week's ballot includes one question on citizenship and four others on increasing protections for workers who are dismissed, in precarious situations or involved in workplace accidents. The changes are being pushed by the left-wing CGIL trade union. "We want to reverse a culture that has prioritised the interests of business over those of workers," CGIL general secretary Maurizio Landini told AFP. The Democratic Party is also backing the proposals -- even if it introduced some of the laws the CGIL wants to repeal while in office in the past. The proposals are notably aimed at measures of the so-called Jobs Act, passed a decade ago by the government of the Democratic Party prime minister, Matteo Renzi, in order to liberalise the labour market. Supporters say the act boosted employment but detractors say it made work more precarious. Under new leadership, the Democratic Party -- which is polling at around 23 percent, behind Meloni's Brothers of Italy at about 30 percent, according to an SWG survey this week -- is seeking to woo working-class voters by backing the referendum reform.
France 24
3 hours ago
- France 24
US aerospace industry anxious as tariffs loom
At the request of President Donald Trump, Commerce Secretary Howard Lutnick's department launched an investigation on May 1 to determine whether to impose tariffs of between 10 and 20 percent on civil aircraft and parts, including engines. The US industry those tariffs were crafted to protect swiftly let the administration know it was not interested. "Imposing broad tariff or non-tariff trade barriers on the imports of civil aviation technology would risk reversing decades of industrial progress and harm the domestic supply chain," the Aerospace Industries Association (AIA) said in a letter addressed to Lutnick and obtained by AFP. The interested parties were given until June 3 to communicate their positions. The very next day, Lutnick announced that Washington aimed to "set the standard for aircraft part tariffs" by the end of this month. "The key is to protect that industry," he said, adding: "We will use these tariffs for the betterment of American industry." But AIA and the Airlines for America (A4A) trade association voiced fear that far from helping, the tariffs would end up harming US manufacturers. No fix needed "Unlike other industries, the civil aviation manufacturing industry prioritizes domestic production of high-value components and final assembly," AIA pointed out. According to the organization, US aerospace and defense exports reached $135.9 billion in 2023, including $113.9 billion for civil aviation alone. This allowed the sector to generate a trade surplus of $74.5 billion and to invest $34.5 billion in research and development, it said. The sector employs more than 2.2 million people in the United States across more than 100,000 companies, which in 2023 produced goods worth nearly $545 billion. In its response to Lutnick, the A4A highlighted how beneficial the international Agreement on Trade in Commercial Aviation (ATCA) had been by helping to eliminate tariffs and trade barriers over nearly half a century. "The US civil aviation industry is the success story that President Trump is looking for as it leads civil aerospace globally," it insisted. A full 84 percent of production was already American, it said, stressing that Washington "does not need to fix the 16 percent" remaining. "The current trade framework has enhanced our economic and national security and is a critical component to maintaining our national security moving forward," it said. For manufacturers, the potential tariffs would act like sand jamming a well-oiled machine that has been running smoothly for decades, experts warned. They would also throw off balance an ultra-sensitive supply chain still recovering from the Covid-19 pandemic. 'Competitive disadvantage' "To avoid the situation getting worse, we advocate to keep aerospace outside of trade wars," Willie Walsh, head of the International Air Transport Association (IATA), told the organization's general assembly last week. AIA meanwhile stressed that "aircraft and parts are already in high demand and have a limited supply." "Integrating new suppliers and expanding capacity is complex, timely, and costly," it warned, pointing out that finding suppliers capable of meeting rigorous safety certifications could "take up to 10 years." Delta Air Lines also argued for sticking with the status quo, cautioning that the proposed tariffs "would hinder Delta's ability to maintain its current trajectory." "If component parts incur tariffs upon entering the United States, Delta will be at a competitive disadvantage to foreign competitors," it said. "The action would also impose an unexpected tax on Delta's purchases of aircraft contracted years in advance." Delta chief Ed Bastian insisted in late April that the airline "will not be paying tariffs on any aircraft deliveries we take," adding that it was "working very closely with (European group) Airbus" to minimize the impact. Delta pointed out in its letter to Lutnick that it currently had 100 aircraft on order from Boeing, and that it was demanding that its Airbus A220s be produced primarily in Mobile, Alabama. But if the tariffs are imposed, it warned, "Delta would likely be forced to cancel existing contracts and reconsider contracts under negotiation."
France 24
3 hours ago
- France 24
Trump sends National Guard to Los Angeles over immigration raids protests
US President Donald Trump deployed 2,000 troops on Saturday to handle escalating protests against immigration enforcement raids in the Los Angeles area, a move the state's governor termed "purposefully inflammatory." Federal agents clashed with angry crowds in a Los Angeles suburb as protests stretched into a second night Saturday, shooting flash-bang grenades and shutting part of a freeway amid raids on undocumented migrants, reports said. The standoff took place in Paramount, where demonstrators had gathered near a Home Depot that was being used as a staging area by federal immigration officials, the Fox 11 news outlet reported. They were met by federal agents in gas masks, who lobbed flash-bang grenades and tear gas at the crowd, according to news reports and social media posts. Since taking office in January, Republican Trump has delivered on a promise to crack down hard on the entry and presence of undocumented migrants -- who he has likened to "monsters" and "animals." Late Saturday, Trump signed a memo deploying 2,000 National Guardsmen "to address the lawlessness that has been allowed to fester," White House Press Secretary Karoline Leavitt said in a statement. "The Trump Administration has a zero tolerance policy for criminal behavior and violence, especially when that violence is aimed at law enforcement officers trying to do their jobs." About an hour before the White House confirmed the deployment, California Governor Gavin Newsom, a Democrat, said he opposed the move. "That move is purposefully inflammatory and will only escalate tensions," he said on social media platform X. "We are in close coordination with the city and county, and there is currently no unmet need." The protests came a day after masked and armed immigration agents carried out high-profile workplace raids in separate parts of Los Angeles, attracting angry crowds and setting off hours-long standoffs. LA Mayor Karen Bass acknowledged that some city residents were "feeling fear" following the federal immigration enforcement actions. "Everyone has the right to peacefully protest, but let me be clear: violence and destruction are unacceptable, and those responsible will be held accountable," she said on X. Roadblocks and chants FBI Deputy Director Dan Bongino said multiple arrests had been made following Friday's clashes. "You bring chaos, and we'll bring handcuffs. Law and order will prevail," he said on X. On Saturday, amid chants for Immigration and Customs Enforcement (ICE) agents to get out, some protestors waved Mexican flags while others set a US flag on fire, the Los Angeles Times reported. Cement blocks and overturned shopping carts served as crude roadblocks. A crowd swarmed a US Marshals Service bus exiting a nearby freeway, with authorities later closing on and off ramps to keep protesters from taking over the highway and to stop new people from flowing in. The White House has taken a hard line against the protests, with deputy chief of staff Stephen Miller calling them "an insurrection against the laws and sovereignty of the United States." Los Angeles, the second-most populous city in the United States, is one of the most diverse metropolises in the country. The suburb of Paramount, home to about 50,000 people, is 82 percent Hispanic or Latino, according to US Census data.
